KMDAKamada Ltd.

$495M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$24M-2.7% YoY

Gross Profit

$7M30.7% margin

Operating Income

-$2M-9.7% margin

Net Income

-$4M-16.6% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-16.0%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$10M

Stock-Based Comp.

$376,000

Balance Sheet

Total Assets

$304M

Total Liabilities

$133M

Stockholders' Equity

$172M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$24M	-2.7%
Gross Profit	$7M	$9M	-20.2%
Operating Income	-$2M	$1M	-319.3%
Net Income	-$4M	$937,000	-518.5%

KMDA Q2 2022 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena